Largest Drug Manufacturers - Specialty & Generic Companies by Market Cap
The Drug Manufacturers - Specialty & Generic sector has 627 publicly listed stocks with a combined market cap of $1.17 Trillion. Takeda Pharmaceutical Co Ltd ADR leads the sector with a market cap of $52.60 Billion. This ranking covers all Drug Manufacturers - Specialty & Generic stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
Companies Listed
Largest Company
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 1 |
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
$52.60 Billion | $52.60 Billion | USA | $16.65 | +0.30% | -6.72% | 71.71 Million |
| 2 |
Jiangsu Hengrui Medicine Co Ltd
SHG:600276 |
$50.48 Billion | CN¥344.98 Billion | China | CN¥54.08 | -1.04% | -1.51% | 2.51 Billion |
| 3 |
GALDERMA GROUP AG
NYSE:GALDY |
$48.78 Billion | $48.78 Billion | USA | $43.60 | -3.33% | +5.19% | 767.50K |
| 4 |
Takeda Pharmaceutical Company Limited
F:TKDA |
$43.60 Billion | €37.29 Billion | Germany | €15.50 | +1.97% | +4.73% | 2.00 |
| 5 |
Haleon plc
NYSE:HLN |
$40.34 Billion | $40.34 Billion | USA | $9.87 | -2.37% | +1.65% | 244.55 Million |
| 6 |
Galderma Group N
SW:GALD |
$37.01 Billion | CHF29.28 Billion | Switzerland | CHF175.75 | -2.71% | +3.81% | 9.70 Million |
| 7 |
Teva Pharmaceutical Industries Limited
F:TEV |
$34.58 Billion | €29.58 Billion | Germany | €28.60 | +4.00% | +9.58% | 27.27K |
| 8 |
Zoetis Inc
NYSE:ZTS |
$34.06 Billion | $34.06 Billion | USA | $77.29 | +1.66% | +3.65% | 123.67 Million |
| 9 |
Sandoz Group AG
SW:SDZ |
$28.94 Billion | CHF22.89 Billion | Switzerland | CHF65.76 | -2.38% | +1.92% | 17.76 Million |
| 10 |
HANSOH PHARMAC. HD-00001
F:3KY |
$23.69 Billion | €20.26 Billion | Germany | €3.51 | -0.99% | -2.50% | 0.00 |
| 11 |
Merck KGaA
XETRA:MRK |
$21.63 Billion | €18.50 Billion | Germany | €143.15 | +0.21% | +2.80% | 6.51 Million |
| 12 |
United Therapeutics Corporation
NASDAQ:UTHR |
$21.42 Billion | $21.42 Billion | USA | $517.71 | -1.54% | -2.23% | 9.11 Million |
| 13 |
Viatris Inc
NASDAQ:VTRS |
$18.99 Billion | $18.99 Billion | USA | $17.56 | -1.13% | +1.62% | 222.04 Million |
| 14 |
Torrent Pharmaceuticals Limited
NSE:TORNTPHARM |
$18.75 Billion | Rs1.73 Trillion | India | Rs5122.80 | +4.58% | +1.63% | 20.03 Million |
| 15 |
Swedish Orphan Biovitrum AB (publ)
ST:SOBI |
$17.52 Billion | Skr162.75 Billion | Sweden | Skr470.60 | -0.42% | +2.66% | 11.41 Million |
| 16 |
MERCK KGAA NAM.SP.ADR
F:MRKC |
$17.07 Billion | €14.60 Billion | Germany | €22.60 | -2.59% | -1.74% | 1.20K |
| 17 |
Yunnan Baiyao Group Co Ltd
SHE:000538 |
$13.80 Billion | CN¥94.32 Billion | China | CN¥52.86 | +0.21% | +2.24% | 286.75 Million |
| 18 |
Zhejiang Nhu Co Ltd
SHE:002001 |
$13.50 Billion | CN¥92.23 Billion | China | CN¥30.01 | -1.67% | -5.51% | 801.66 Million |
| 19 |
Neurocrine Biosciences Inc
NASDAQ:NBIX |
$13.03 Billion | $13.03 Billion | USA | $166.80 | -10.08% | -4.22% | 30.87 Million |
| 20 |
IPSEN SA SP.ADR 1/4/ EO 1
F:I7G0 |
$12.92 Billion | €11.05 Billion | Germany | €40.80 | +3.03% | +0.00% | 3.43K |
| 21 |
Cipla Limited
NSE:CIPLA |
$12.87 Billion | Rs1.19 Trillion | India | Rs1473.20 | +0.46% | +5.76% | 33.28 Million |
| 22 |
Zydus Lifesciences Limited
NSE:ZYDUSLIFE |
$12.26 Billion | Rs1.13 Trillion | India | Rs1126.80 | +1.05% | +1.17% | 28.79 Million |
| 23 |
Lupin Limited
NSE:LUPIN |
$11.93 Billion | Rs1.10 Trillion | India | Rs2415.00 | -0.26% | +0.78% | 19.56 Million |
| 24 |
Dr. Reddy’s Laboratories Ltd ADR
NYSE:RDY |
$11.16 Billion | $11.16 Billion | USA | $13.58 | +5.76% | +4.95% | 58.86 Million |
| 25 |
Mankind Pharma Ltd
NSE:MANKIND |
$11.03 Billion | Rs1.02 Trillion | India | Rs2469.60 | -4.13% | -3.43% | 10.78 Million |
| 26 |
Elanco Animal Health
NYSE:ELAN |
$10.85 Billion | $10.85 Billion | USA | $26.37 | -0.34% | +6.42% | 91.72 Million |
| 27 |
Laurus Labs Limited
NSE:LAURUSLABS |
$10.60 Billion | Rs980.49 Billion | India | Rs1816.20 | +1.96% | +15.11% | 67.88 Million |
| 28 |
Ipsen SA
PA:IPN |
$10.50 Billion | €8.98 Billion | France | €167.20 | +6.36% | +2.58% | 2.73 Million |
| 29 |
Aurobindo Pharma Limited
NSE:AUROPHARMA |
$9.83 Billion | Rs909.21 Billion | India | Rs1580.20 | +0.25% | +3.73% | 22.77 Million |
| 30 |
Krka d. d
WAR:KRK |
$9.43 Billion | zł34.25 Billion | Poland | zł1130.00 | +0.00% | +0.00% | 3.18K |
| 31 |
Dr. Reddy's Laboratories Limited
F:RDDA |
$9.23 Billion | €7.89 Billion | Germany | €10.10 | +0.00% | -7.34% | 500.00 |
| 32 |
Alkermes Plc
NASDAQ:ALKS |
$7.49 Billion | $7.49 Billion | USA | $48.99 | -2.08% | -7.51% | 44.48 Million |
| 33 |
Huadong Medicine Co Ltd
SHE:000963 |
$7.47 Billion | CN¥51.06 Billion | China | CN¥29.11 | -1.29% | -4.21% | 635.51 Million |
| 34 |
Alkem Laboratories Limited
NSE:ALKEM |
$7.44 Billion | Rs687.68 Billion | India | Rs5751.50 | -1.12% | +2.67% | 3.84 Million |
| 35 |
Liquidia Technologies Inc
NASDAQ:LQDA |
$7.24 Billion | $7.24 Billion | USA | $84.11 | -3.10% | -5.53% | 35.11 Million |
| 36 |
Shanghai Fosun Pharmaceutical Group Co Ltd
SHG:600196 |
$7.20 Billion | CN¥49.21 Billion | China | CN¥23.23 | +0.26% | -2.02% | 794.30 Million |
| 37 |
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
$6.56 Billion | €5.61 Billion | Germany | €33.12 | +3.24% | +3.89% | 64.00 |
| 38 |
Abbott India Limited
NSE:ABBOTINDIA |
$6.39 Billion | Rs590.73 Billion | India | Rs27800.00 | +0.89% | -3.10% | 306.96K |
| 39 |
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
SHE:000999 |
$6.29 Billion | CN¥42.95 Billion | China | CN¥25.81 | -0.42% | +2.71% | 386.67 Million |
| 40 |
Shenzhen Salubris Pharmaceuticals Co Ltd
SHE:002294 |
$5.43 Billion | CN¥37.10 Billion | China | CN¥33.28 | +0.39% | -4.81% | 1.07 Billion |
| 41 |
Beijing Tongrentang Co Ltd
SHG:600085 |
$5.28 Billion | CN¥36.10 Billion | China | CN¥26.32 | +0.15% | +1.94% | 334.01 Million |
| 42 |
Amneal Pharmaceuticals, Inc. Class A Common Stock
NASDAQ:AMRX |
$5.21 Billion | $5.21 Billion | USA | $18.32 | -0.97% | +1.95% | 43.55 Million |
| 43 |
H Lundbeck A/S
CO:HLUN-B |
$5.15 Billion | Dkr32.91 Billion | Denmark | Dkr41.50 | -1.14% | -2.26% | 10.70 Million |
| 44 |
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423 |
$5.15 Billion | CN¥35.17 Billion | China | CN¥54.62 | -1.12% | +6.51% | 150.70 Million |
| 45 |
Alkermes plc
F:8AK |
$4.96 Billion | €4.25 Billion | Germany | €41.83 | -1.83% | -8.89% | 30.00 |
| 46 |
Lantheus Holdings Inc
NASDAQ:LNTH |
$4.93 Billion | $4.93 Billion | USA | $99.64 | -1.35% | -3.94% | 21.97 Million |
| 47 |
Changchun High & New Technology Industries Group Inc
SHE:000661 |
$4.84 Billion | CN¥33.04 Billion | China | CN¥81.00 | +0.63% | +3.37% | 280.15 Million |
| 48 |
Ajanta Pharma Limited
NSE:AJANTPHARM |
$4.68 Billion | Rs432.93 Billion | India | Rs3465.20 | +0.84% | +0.74% | 2.73 Million |
| 49 |
Gland Pharma Limited
NSE:GLAND |
$4.47 Billion | Rs412.88 Billion | India | Rs2502.90 | -0.56% | +5.27% | 13.61 Million |
| 50 |
Suven Pharmaceuticals Limited
NSE:SUVENPHAR |
$4.40 Billion | Rs406.97 Billion | India | Rs1063.80 | +0.00% | +0.00% | 191.99K |
| 51 |
Humanwell Healthcare Group Co Ltd
SHG:600079 |
$4.28 Billion | CN¥29.23 Billion | China | CN¥17.91 | -0.17% | +2.46% | 299.89 Million |
| 52 |
JB Chemicals & Pharmaceuticals Limited
NSE:JBCHEPHARM |
$4.18 Billion | Rs386.77 Billion | India | Rs2408.90 | -3.87% | -1.10% | 13.52 Million |
| 53 |
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603 |
$4.13 Billion | CN¥28.22 Billion | China | CN¥16.89 | +1.56% | -0.30% | 783.94 Million |
| 54 |
Emcure Pharmaceuticals Ltd
NSE:EMCURE |
$4.02 Billion | Rs371.61 Billion | India | Rs1960.10 | +2.57% | +4.85% | 3.56 Million |
| 55 |
Indivior PLC Ordinary Shares
NASDAQ:INDV |
$3.91 Billion | $3.91 Billion | USA | $40.01 | -0.52% | -1.23% | 33.30 Million |
| 56 |
Siegfried Holding Ltd
SW:SFZN |
$3.71 Billion | CHF2.94 Billion | Switzerland | CHF75.75 | +0.07% | +6.99% | 1.97 Million |
| 57 |
Hims Hers Health Inc
NYSE:HIMS |
$3.71 Billion | $3.71 Billion | USA | $27.77 | +2.70% | -15.18% | 345.87 Million |
| 58 |
Yuhan Corp.
KO:000100 |
$3.67 Billion | ₩5.41 Trillion | Korea | ₩73500.00 | -0.68% | +2.94% | 7.42 Million |
| 59 |
Zhejiang Huahai Pharmaceutical Co Ltd
SHG:600521 |
$3.66 Billion | CN¥25.03 Billion | China | CN¥16.72 | +2.45% | -0.12% | 1.15 Billion |
| 60 |
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566 |
$3.62 Billion | CN¥24.74 Billion | China | CN¥26.84 | -0.33% | -0.67% | 208.62 Million |
| 61 |
Amneal Pharmaceuticals, Inc. Class A Common Stock
NYSE:AMRX |
$3.57 Billion | $3.57 Billion | USA | $12.18 | +2.01% | -2.72% | 43.40 Million |
| 62 |
Betta Pharmaceuticals Co Ltd
SHE:300558 |
$3.54 Billion | CN¥24.19 Billion | China | CN¥57.50 | +3.08% | -5.35% | 546.10 Million |
| 63 |
Tasly Pharmaceutical Group Co Ltd
SHG:600535 |
$3.52 Billion | CN¥24.08 Billion | China | CN¥16.12 | +1.51% | +1.07% | 516.25 Million |
| 64 |
Aspen Pharmacare Holdings Ltd
JSE:APN |
$3.52 Billion | ZAC6.62 Trillion | South Africa | ZAC14910.00 | +0.70% | -0.29% | 26.46 Million |
| 65 |
INDIVIOR PLC DL 050
F:2IVB |
$3.51 Billion | €3.01 Billion | Germany | €27.00 | -1.53% | -0.74% | 1.51K |
| 66 |
Laboratorios Farmaceuticos ROVI
MC:ROVI |
$3.50 Billion | €2.99 Billion | Spain | €58.55 | -1.18% | +0.77% | 3.70 Million |
| 67 |
Wockhardt Limited
NSE:WOCKPHARMA |
$3.44 Billion | Rs318.44 Billion | India | Rs1959.70 | +2.93% | +5.95% | 14.34 Million |
| 68 |
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA |
$3.44 Billion | $3.44 Billion | USA | $74.34 | -4.94% | +17.91% | 19.79 Million |
| 69 |
Apeloa Pharmaceutical Co Ltd
SHE:000739 |
$3.43 Billion | CN¥23.42 Billion | China | CN¥20.22 | +1.00% | -1.80% | 513.94 Million |
| 70 |
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262 |
$3.28 Billion | CN¥22.45 Billion | China | CN¥22.10 | +0.09% | +1.47% | 350.09 Million |
| 71 |
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317 |
$3.26 Billion | CN¥22.29 Billion | China | CN¥26.22 | +4.92% | -3.18% | 1.48 Billion |
| 72 |
Jilin Aodong Pharmaceutical Group Co Ltd
SHE:000623 |
$3.21 Billion | CN¥21.97 Billion | China | CN¥18.37 | +0.38% | +0.33% | 397.53 Million |
| 73 |
Tianjin Zhongxin Pharmaceutical Group Corp Ltd
SHG:600329 |
$3.19 Billion | CN¥21.83 Billion | China | CN¥38.29 | -0.03% | +2.05% | 119.07 Million |
| 74 |
SIMCERE PHARMAC. GRP LTD
F:S2P |
$3.17 Billion | €2.72 Billion | Germany | €1.33 | -1.48% | -5.00% | 0.00 |
| 75 |
Regencell Bioscience Holdings Ltd
NASDAQ:RGC |
$3.06 Billion | $3.06 Billion | USA | $6.18 | +4.04% | +9.96% | 11.55 Million |
| 76 |
ASPEN PHAR.UN.ADR /1 O.N.
F:LDZU |
$2.95 Billion | €2.52 Billion | Germany | €6.90 | +4.55% | +0.73% | 240.00 |
| 77 |
Hypera S.A
SA:HYPE3 |
$2.94 Billion | R$14.97 Billion | Brazil | R$21.27 | -1.76% | +5.82% | 64.80 Million |
| 78 |
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773 |
$2.90 Billion | CN¥19.85 Billion | China | CN¥21.54 | +0.37% | +0.42% | 315.80 Million |
| 79 |
Walvax BioTech
SHE:300142 |
$2.88 Billion | CN¥19.70 Billion | China | CN¥12.32 | +1.15% | -7.09% | 1.95 Billion |
| 80 |
Hanmi Pharm Co Ltd
KO:128940 |
$2.87 Billion | ₩4.23 Trillion | Korea | ₩333500.00 | +7.06% | -14.27% | 2.62 Million |
| 81 |
Piramal Pharma Limited
NSE:PPLPHARMA |
$2.80 Billion | Rs259.13 Billion | India | Rs195.61 | -0.56% | +8.17% | 200.90 Million |
| 82 |
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
$2.75 Billion | CN¥18.81 Billion | China | CN¥1.36 | +0.74% | -0.73% | 5.53 Billion |
| 83 |
Joincare Pharmaceutical Group Industry Co Ltd
SHG:600380 |
$2.74 Billion | CN¥18.75 Billion | China | CN¥10.25 | +0.10% | -0.58% | 436.54 Million |
| 84 |
Hybio Pharmaceutical
SHE:300199 |
$2.73 Billion | CN¥18.64 Billion | China | CN¥21.10 | +4.46% | +0.29% | 1.45 Billion |
| 85 |
Livzon Pharmaceutical Group Inc
SHE:000513 |
$2.68 Billion | CN¥18.31 Billion | China | CN¥31.13 | +0.39% | +1.33% | 167.92 Million |
| 86 |
Neuland Laboratories Limited
NSE:NEULANDLAB |
$2.64 Billion | Rs244.32 Billion | India | Rs19043.00 | -0.83% | +3.32% | 905.12K |
| 87 |
Almirall S.A.
MC:ALM |
$2.63 Billion | €2.25 Billion | Spain | €11.10 | -1.07% | +0.36% | 3.23 Million |
| 88 |
Bausch Health Companies Inc
TO:BHC |
$2.61 Billion | CA$3.60 Billion | Canada | CA$9.65 | +14.47% | +53.66% | 14.96 Million |
| 89 |
Supernus Pharmaceuticals Inc
NASDAQ:SUPN |
$2.59 Billion | $2.59 Billion | USA | $44.63 | -2.15% | -5.42% | 16.78 Million |
| 90 |
Curaleaf Holdings Inc.
TO:CURA |
$2.52 Billion | CA$3.49 Billion | Canada | CA$12.41 | +1.06% | -3.95% | 3.28 Million |
| 91 |
China Resources Double-Crane Pharmaceutical Co Ltd
SHG:600062 |
$2.47 Billion | CN¥16.90 Billion | China | CN¥16.27 | +0.25% | -4.91% | 265.33 Million |
| 92 |
Jiangzhong Pharmaceutical Co Ltd
SHG:600750 |
$2.45 Billion | CN¥16.77 Billion | China | CN¥26.39 | +0.50% | +4.51% | 118.84 Million |
| 93 |
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858 |
$2.43 Billion | CN¥16.62 Billion | China | CN¥15.76 | +0.90% | -0.25% | 181.82 Million |
| 94 |
Shanghai Haoyuan Chemexpress Co. Ltd. A
SHG:688131 |
$2.41 Billion | CN¥16.48 Billion | China | CN¥77.72 | +1.79% | +11.11% | 176.97 Million |
| 95 |
Tonghua Dongbao Pharmaceutical Co Ltd
SHG:600867 |
$2.40 Billion | CN¥16.39 Billion | China | CN¥8.37 | +0.36% | +3.08% | 876.88 Million |
| 96 |
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd
SHE:000766 |
$2.40 Billion | CN¥16.38 Billion | China | CN¥16.95 | +2.42% | +7.96% | 708.97 Million |
| 97 |
Yipinhong Pharmaceutical Co Ltd Class A
SHE:300723 |
$2.33 Billion | CN¥15.94 Billion | China | CN¥35.30 | +4.13% | -0.65% | 402.82 Million |
| 98 |
Prestige Brand Holdings Inc
NYSE:PBH |
$2.33 Billion | $2.33 Billion | USA | $50.22 | +0.54% | +2.62% | 10.53 Million |
| 99 |
Dermapharm Holding SE
XETRA:DMP |
$2.26 Billion | €1.93 Billion | Germany | €41.00 | -1.91% | +1.61% | 480.32K |
| 100 |
BioCryst Pharmaceuticals Inc
NASDAQ:BCRX |
$2.18 Billion | $2.18 Billion | USA | $8.98 | -2.81% | -4.26% | 98.20 Million |
| 101 |
Harbin Pharmaceutical Group Co Ltd
SHG:600664 |
$2.17 Billion | CN¥14.83 Billion | China | CN¥5.89 | +5.94% | -1.83% | 7.84 Billion |
| 102 |
Avadel Pharmaceuticals PLC
NASDAQ:AVDL |
$2.12 Billion | $2.12 Billion | USA | $21.64 | +0.05% | +0.28% | 72.66 Million |
| 103 |
Fujian Cosunter Pharmaceutical Co Ltd
SHE:300436 |
$2.07 Billion | CN¥14.12 Billion | China | CN¥88.68 | +3.42% | -0.23% | 225.83 Million |
| 104 |
Shenzhen Kangtai Biological Products Co Ltd
SHE:300601 |
$2.05 Billion | CN¥14.02 Billion | China | CN¥12.55 | +0.88% | +2.87% | 426.98 Million |
| 105 |
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267 |
$2.03 Billion | CN¥13.88 Billion | China | CN¥11.58 | +0.52% | -3.98% | 1.11 Billion |
| 106 |
Eris Lifesciences Limited
NSE:ERIS |
$2.00 Billion | Rs184.53 Billion | India | Rs1354.70 | -1.49% | -2.93% | 2.25 Million |
| 107 |
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
SHG:603707 |
$1.91 Billion | CN¥13.07 Billion | China | CN¥8.09 | -0.61% | +2.80% | 361.01 Million |
| 108 |
Henan Lingrui Pharmaceutical Co Ltd
SHG:600285 |
$1.91 Billion | CN¥13.04 Billion | China | CN¥23.00 | -2.04% | +1.72% | 269.11 Million |
| 109 |
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456 |
$1.90 Billion | CN¥12.95 Billion | China | CN¥14.56 | +1.25% | -1.49% | 723.38 Million |
| 110 |
Wedge Industrial Co Ltd
SHE:000534 |
$1.84 Billion | CN¥12.59 Billion | China | CN¥24.70 | -1.16% | -5.98% | 502.51 Million |
| 111 |
HUTCHMED (China) Limited
F:H7T1 |
$1.84 Billion | €1.57 Billion | Germany | €9.60 | +0.00% | +0.00% | 0.00 |
| 112 |
Tibet Rhodiola Pharmaceutical Holding Co
SHG:600211 |
$1.82 Billion | CN¥12.47 Billion | China | CN¥38.68 | -0.28% | +0.44% | 121.07 Million |
| 113 |
Fagron NV
BR:FAGR |
$1.81 Billion | €1.55 Billion | Belgium | €23.75 | +1.50% | +0.21% | 1.69 Million |
| 114 |
Natco Pharma Limited
NSE:NATCOPHARM |
$1.78 Billion | Rs164.24 Billion | India | Rs917.00 | -1.38% | -0.17% | 11.78 Million |
| 115 |
ANI Pharmaceuticals Inc
NASDAQ:ANIP |
$1.78 Billion | $1.78 Billion | USA | $79.24 | -1.48% | +0.90% | 6.52 Million |
| 116 |
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755 |
$1.77 Billion | CN¥12.10 Billion | China | CN¥13.04 | +2.35% | +0.00% | 354.40 Million |
| 117 |
Shenzhen Hepalink Pharmaceutical Co Ltd
SHE:002399 |
$1.77 Billion | CN¥12.09 Billion | China | CN¥9.69 | +1.15% | +0.41% | 140.22 Million |
| 118 |
Dynavax Technologies Corporation
NASDAQ:DVAX |
$1.76 Billion | $1.76 Billion | USA | $15.50 | +0.00% | +0.10% | 76.22 Million |
| 119 |
Shanghai Shyndec Pharmaceutical Co Ltd
SHG:600420 |
$1.73 Billion | CN¥11.86 Billion | China | CN¥8.84 | +0.00% | +1.73% | 306.98 Million |
| 120 |
Zhejiang Jingxin Pharmaceutical Co Ltd
SHE:002020 |
$1.72 Billion | CN¥11.74 Billion | China | CN¥13.64 | +0.29% | -3.60% | 656.42 Million |
| 121 |
Zhejiang Medicine Co Ltd
SHG:600216 |
$1.70 Billion | CN¥11.65 Billion | China | CN¥12.11 | +0.08% | -0.90% | 519.40 Million |
| 122 |
Alembic Pharmaceuticals Limited
NSE:APLLTD |
$1.69 Billion | Rs156.67 Billion | India | Rs797.05 | -1.84% | -4.38% | 3.28 Million |
| 123 |
Amylyx Pharmaceuticals Inc
NASDAQ:AMLX |
$1.64 Billion | $1.64 Billion | USA | $20.31 | -2.12% | +15.46% | 42.63 Million |
| 124 |
Zhejiang CONBA Pharmaceutical Co Ltd
SHG:600572 |
$1.61 Billion | CN¥11.02 Billion | China | CN¥4.34 | +0.46% | +0.70% | 1.23 Billion |
| 125 |
Jubilant Pharmova Limited
NSE:JUBLPHARMA |
$1.60 Billion | Rs148.12 Billion | India | Rs935.15 | -2.76% | -3.67% | 3.25 Million |
| 126 |
Shenzhen Chipscreen Biosciences Co
SHG:688321 |
$1.58 Billion | CN¥10.79 Billion | China | CN¥26.46 | +1.97% | -11.59% | 401.49 Million |
| 127 |
Mayinglong Pharmaceutical Group Co Ltd
SHG:600993 |
$1.58 Billion | CN¥10.78 Billion | China | CN¥25.01 | +0.16% | +5.57% | 170.18 Million |
| 128 |
Yantai Dongcheng Pharmaceutical Co Ltd
SHE:002675 |
$1.55 Billion | CN¥10.57 Billion | China | CN¥12.82 | +0.23% | +1.99% | 255.12 Million |
| 129 |
BORA PHARMACEUTICALS LTD
TW:6472 |
$1.54 Billion | NT$48.72 Billion | Taiwan | NT$382.50 | +2.27% | -4.61% | 26.88 Million |
| 130 |
Guangdong Taienkang Pharmaceutical Co. Ltd
SHE:301263 |
$1.53 Billion | CN¥10.46 Billion | China | CN¥20.49 | +6.00% | +5.62% | 182.65 Million |
| 131 |
Faes Farma SA
MC:FAE |
$1.50 Billion | €1.28 Billion | Spain | €4.56 | +0.66% | +0.44% | 3.12 Million |
| 132 |
Hanall Biopharma
KO:009420 |
$1.49 Billion | ₩2.20 Trillion | Korea | ₩43400.00 | +11.28% | -12.59% | 11.51 Million |
| 133 |
Tianjin Chase Sun Pharmaceutical Co Ltd
SHE:300026 |
$1.48 Billion | CN¥10.12 Billion | China | CN¥3.37 | +0.60% | +0.60% | 1.68 Billion |
| 134 |
Lotus Pharmaceutical Co Ltd
TW:1795 |
$1.45 Billion | NT$45.99 Billion | Taiwan | NT$175.00 | +1.16% | -7.16% | 55.06 Million |
| 135 |
Harrow Health Inc
NASDAQ:HROW |
$1.42 Billion | $1.42 Billion | USA | $38.77 | -0.44% | -7.43% | 13.82 Million |
| 136 |
Perrigo Company PLC
NYSE:PRGO |
$1.40 Billion | $1.40 Billion | USA | $10.11 | -1.94% | +0.10% | 65.85 Million |
| 137 |
Xeris Pharmaceuticals Inc
NASDAQ:XERS |
$1.39 Billion | $1.39 Billion | USA | $8.08 | -4.04% | -3.92% | 44.04 Million |
| 138 |
CONSUN PHARMAC.GR.HD -10
F:C1P |
$1.35 Billion | €1.15 Billion | Germany | €1.50 | +0.00% | +0.00% | 0.00 |
| 139 |
Guobang Pharma Ltd
SHG:605507 |
$1.33 Billion | CN¥9.08 Billion | China | CN¥16.24 | -0.37% | +0.74% | 166.41 Million |
| 140 |
Shilpa Medicare Limited
NSE:SHILPAMED |
$1.29 Billion | Rs119.55 Billion | India | Rs611.25 | +1.38% | +1.27% | 19.43 Million |
| 141 |
Zhejiang Hisoar Pharmaceutical Co Ltd
SHE:002099 |
$1.29 Billion | CN¥8.82 Billion | China | CN¥5.45 | +0.37% | +6.45% | 535.07 Million |
| 142 |
Perrigo Company plc
F:PIG |
$1.28 Billion | €1.10 Billion | Germany | €8.85 | -1.21% | -5.08% | 0.00 |
| 143 |
Chongqing Taiji Industry Group Co Ltd
SHG:600129 |
$1.27 Billion | CN¥8.70 Billion | China | CN¥15.78 | +3.00% | +0.19% | 915.82 Million |
| 144 |
Changzhou Qianhong Biopharma Co Ltd
SHE:002550 |
$1.27 Billion | CN¥8.69 Billion | China | CN¥6.79 | +0.15% | +0.44% | 778.64 Million |
| 145 |
PharmaBlock Sciences Nanjing Inc Class A
SHE:300725 |
$1.25 Billion | CN¥8.56 Billion | China | CN¥36.62 | +2.29% | -5.62% | 416.06 Million |
| 146 |
Zhejiang Xianju Pharmaceutical Co Ltd
SHE:002332 |
$1.24 Billion | CN¥8.48 Billion | China | CN¥8.57 | +0.47% | +2.15% | 325.90 Million |
| 147 |
Porton Fine Chemicals Ltd
SHE:300363 |
$1.24 Billion | CN¥8.45 Billion | China | CN¥15.54 | +3.81% | -4.66% | 778.36 Million |
| 148 |
Teva Pharmaceutical Industries Ltd
TA:TEVA |
$1.23 Billion | ILA458.22 Billion | Israel | ILA10560.00 | +10.17% | +8.47% | 23.12 Million |
| 149 |
BioGaia AB (publ)
ST:BIOG-B |
$1.23 Billion | Skr11.39 Billion | Sweden | Skr115.60 | -0.17% | -2.20% | 3.14 Million |
| 150 |
North China Pharmaceutical Co Ltd
SHG:600812 |
$1.21 Billion | CN¥8.27 Billion | China | CN¥4.82 | -0.21% | +0.00% | 589.49 Million |
Track real-time market capitalization of largest public companies in the Drug Manufacturers - Specialty & Generic industry. Compare marketcap, analyze stock performance, and discover leading drug manufacturers - specialty & generic corporations. View all industries